Financials data is unavailable for this security.
View more
Year on year OLBA Healthcare Holdings Inc grew revenues 7.33% from 110.47bn to 118.56bn while net income improved 6.09% from 1.41bn to 1.50bn.
Gross margin | 11.50% |
---|---|
Net profit margin | 1.25% |
Operating margin | 1.88% |
Return on assets | 3.53% |
---|---|
Return on equity | 14.24% |
Return on investment | 11.89% |
More ▼
Cash flow in JPYView more
In 2024, OLBA Healthcare Holdings Inc increased its cash reserves by 13.62%, or 321.41m. The company earned 2.08bn from its operations for a Cash Flow Margin of 1.76%. In addition the company used 673.03m on investing activities and also paid 1.09bn in financing cash flows.
Cash flow per share | 350.91 |
---|---|
Price/Cash flow per share | 6.04 |
Book value per share | 1,863.86 |
---|---|
Tangible book value per share | 1,755.59 |
More ▼
Balance sheet in JPYView more
Current ratio | 1.16 |
---|---|
Quick ratio | 0.9459 |
Total debt/total equity | 0.2722 |
---|---|
Total debt/total capital | 0.214 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 14.29% and 7.14%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 3.53% |
---|---|
Div growth rate (5 year) | 14.87% |
Payout ratio (TTM) | 32.58% |
EPS growth(5 years) | 12.73 |
---|---|
EPS (TTM) vs TTM 1 year ago | 14.49 |
More ▼